Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

518
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
518
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

682
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
682
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Hazard Ratio01:12

Hazard Ratio

680
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
680
Statistical Significance01:50

Statistical Significance

23.2K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
23.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Data to Knowledge. Advancing Life Sciences: Editorial for the CEN2023 Special Issue.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf-Life Estimation.

Statistics in medicine·2025
Same author

Testing for Similarity of Dose Response in Multiregional Clinical Trials.

Statistics in medicine·2025
Same author

Development of a consensus extension of the estimands framework for cluster randomised trials (CRT-estimands): results from an international Delphi study.

medRxiv : the preprint server for health sciences·2025
Same author

Dose-response characterization: A key to success in drug development.

Clinical trials (London, England)·2025
Same author

Randomization-Based Inference for MCP-Mod.

Statistics in medicine·2025

Related Experiment Video

Updated: Mar 11, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials.

Mohamed Alosh1, Mohammad F Huque2, Frank Bretz3,4

  • 1Division of Biometrics III, Office of Biostatistics, OTS, CDER, FDA, Silver Spring, MD, 20993, U.S.A.

Statistics in Medicine
|November 29, 2016
PubMed
Summary

Investigating treatment effects across patient subgroups is crucial for accurate clinical trial interpretation. Careful analysis is needed to distinguish true treatment benefit variations from random chance, guiding effective treatment application.

Keywords:
negative subgroup treatment effectsupportive subgroup findingstargeted subgrouptreatment-by-subgroup interaction

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.6K

Related Experiment Videos

Last Updated: Mar 11, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.6K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacology

Background:

  • Treatment benefits in clinical trials can vary based on patient characteristics.
  • Understanding treatment effect consistency across subgroups is vital for interpreting trial findings.
  • Subgroup analyses inform how treatments should be applied in diverse patient populations.

Purpose of the Study:

  • To address challenges in interpreting subgroup analyses in clinical trials.
  • To provide guidance on designing and analyzing trials with expected heterogeneity of treatment effects.
  • To ensure proper interpretation of positive study findings in the overall population.

Main Methods:

  • Review of issues related to subgroup analyses in completed clinical trials.
  • Discussion of statistical power limitations in detecting true heterogeneity.
  • Guidance on prospective trial design accounting for subgroup effects.

Main Results:

  • Observed heterogeneity in treatment effects may be due to chance or true biological variation.
  • Standard statistical tests may lack the power to detect genuine subgroup differences.
  • Careful interpretation is required to avoid misattributing observed variations.

Conclusions:

  • Subgroup analyses are essential but require meticulous interpretation.
  • Clinical trial design should proactively address potential treatment effect heterogeneity.
  • Establishing treatment benefit in targeted subgroups and/or the overall population is key.